In fact, uPAR and CXCR4 expression in AML varies according to the FAB subtype (highest expression in M5 and lowest in M0) 21,22,25, thus leukaemia cells seemed a suitable system to validate the expression and function of identified miRs. The gene discussed is CXCR4; the disease is leukemia.